MSD Bets $510M on High-Quality Data to Fuel Post-Keytruda AI Drug Discovery
MSD, which has long dominated the global cancer market with its blockbuster immuno-oncology therapy Keytruda, is investing heavily in artificial...
Search results for "pharmaceutical company"
Seers Surpasses 200 Adopting Hospitals for ‘thynC,’ Upgrading Operations for Rapid Scaling
Seers, a leading wearable artificial intelligence diagnostic monitoring company, is sharpening its commercial strategy by recruiting a veteran...
Curocell’s Homegrown CAR-T Therapy Rimqarto Lands Spotlight in Top Hematology Journal Blood
Curocell, a South Korean clinical-stage biotech company specializing in chimeric antigen receptor T-cell (CAR-T)...
Will a 'Second Gleevec' Emerge? The Race Heats Up for Rare Gastrointestinal Cancer Breakthroughs
A rare cancer can form in the wall of the stomach or intestines: gastrointestinal stromal tumor, or GIST.
South Korean Biotechs Race to Conquer the Untapped Global MASH Market
Fat accumulation in the liver can trigger severe inflammation even in individuals who completely abstain from alcohol.
The Fat-to-Brain Highway: How Aged Garlic Extract Remodels Muscle Health
"If you eat this and do not see sunlight for 100 days, you will become human." According to Korean mythology, those...
Hanmi Pharm Revives 'LAPSCOVERY' Momentum with $1.26B Eli Lilly Licensing Deal
Hanmi Pharmaceutical has licensed its novel drug candidate sonefpeglutide to global pharmaceutical giant Eli Lilly and...
Mexico Greenlights Daewoong’s Envlo, Fueling Latin American Expansion
Daewoong Pharmaceutical announced on May 27 that its type 2 diabetes treatment, Envlo 0.
Complete Remission in Metastatic Pancreatic Cancer: Nesuparib Shows Early Clinical Promise
Early clinical data point to extended survival and the rare possibility of complete remission in metastatic pancreatic...
Ebola spreads rapidly in DRC—how far have new vaccines and treatments come?
A Reuters report said the U.K. media outlet The Guardian reported on the 19th (20th in Korea time) that the World...